Rigel Pharmaceuticals Inc (RIGL)

Other Income/Expenses (Net)

-$1.47M

TTM · Period ending: · USD

RIGL logo

RIGL Other Income/Expenses (Net)

Latest reported-$1.47M
RIGL TTM Other Income/Expenses (Net) ($145.00K → -$1.47M)
High-resolution chart · PNG

RIGL other income/expenses (net) history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Rigel Pharmaceuticals Inc Other Income/Expenses (Net) — Trailing twelve months (TTM) (USD)
Period endingOther Income/Expenses (Net) (USD)
7,683,000
4,065,000
145,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.